Bumrungrad Hospital PCL's gross profit for the
three
months ended in Mar. 2026 was $99.3 Mil. Bumrungrad Hospital PCL's gross profit for the trailing twelve months (TTM) ended in Mar. 2026 was $410.4 Mil.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Bumrungrad Hospital PCL had a gross margin of 51.45% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Bumrungrad Hospital PCL Gross Profit Related Terms
Bumrungrad Hospital PCL Gross Profit Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Bumrungrad Hospital PCL's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bumrungrad Hospital PCL Gross Profit vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Bumrungrad Hospital PCL's Gross Profit distribution charts can be found below:
* The bar in red indicates where Bumrungrad Hospital PCL's Gross Profit falls into.
Gross Profit for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $410.4 Mil.
Gross Profit is the numerator in the calculation of Gross Margin.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Bumrungrad Hospital PCL (BUGDF) has a Gross Profit of $410.4 Mil as of Mar. 2026. Gross Profit equals net sales less total cost of goods sold. View historical data on Bumrungrad Hospital PCL and its competitors.
Is Bumrungrad Hospital PCL's Gross Profit too high?
Bumrungrad Hospital PCL's current Gross Profit is $410.4 Mil. Overall, Bumrungrad Hospital PCL has a GF Score™ of 100/100, reflecting its overall financial health beyond just this single metric.
How does Bumrungrad Hospital PCL's Gross Profit compare to HCA and THC?
Bumrungrad Hospital PCL's Gross Profit of $410.4 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Profit for a Healthcare Providers & Services company?
A good Gross Profit depends on the Healthcare Providers & Services industry context. However, Gross Profit should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Profit mean?
A high Gross Profit can signal that a stock is expensive relative to its fundamentals. Gross Profit equals net sales less total cost of goods sold. View historical data on Bumrungrad Hospital PCL and its competitors. Bumrungrad Hospital PCL's current Gross Profit is $410.4 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bumrungrad Hospital PCL stock overvalued right now?
Bumrungrad Hospital PCL (BUGDF) has a current Gross Profit of $410.4 Mil. The stock's GF Value™ is $5.35, compared to a current price of $4.75 — trading 11.2% below its estimated fair value. The current Gross Profit is $410.4 Mil. Bumrungrad Hospital PCL's overall GF Score™ is 100/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Profit calculated?
Gross Profit is calculated from a company's financial statements. For Bumrungrad Hospital PCL (BUGDF), the current Gross Profit is $410.4 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bumrungrad Hospital PCL (BUGDF) Overvalued in 2026?
Based on GuruFocus' analysis, Bumrungrad Hospital PCL stock appears to be undervalued.
The current stock price of $4.75 is trading 11.2% below its estimated GF Value™ of $5.35.
Key valuation signals for BUGDF:
Gross Profit: $410.4 Mil
GF Value™: $5.35 vs. price of $4.75 (11.2% below fair value)
No single metric tells the full story. See the BUGDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bumrungrad Hospital PCL operates a private hospital business in Bangkok. The company operates several healthcare-related entities, within and outside of Thailand which include Bumrungrad International Hospital, Bumrungrad International Clinic, Vitallife Scientific Wellness Center, VitalLife Skin Clinic, Bumrungrad International Dialysis Clinic, and others. It is a healthcare provider in Thailand providing complete healthcare services for both outpatients and inpatients. The company is the owner and operator of multiple healthcare-related entities. The company has only one main reportable operating segment, which is the hospital and health care center business, and the geographical area of its operations is Thailand.
100GF Score
Get the complete analysis for BUGDF
Gross Profit is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BUGDF has been successfully added to your 
